Syndrome News and Research

RSS

Hormone cycles dictate how the brain absorbs neuroprotective drugs

Consider what we ask of a clinical trial. We gather people who differ in nearly every way that matters, we give them the same drug at the same dose, and then we average the result and call the average truth.

16 Jun 2026

Gut bacteria may help explain why fatigue appears before illness

A small study of healthy Japanese adults found that fatigue was associated with distinct gut microbiome, microbial gene, and fecal metabolite patterns. The findings suggest fatigue may track with altered microbial energy metabolism and oxidative stress-related functional potential, but larger longitudinal studies are needed to test causality and clinical value.

16 Jun 2026

Prevention proves cheaper than treatment for Li-Fraumeni syndrome

Screening people with the rare, inherited cancer-causing condition Li-Fraumeni syndrome (LFS) brings both medical and economic benefits to patients and healthcare systems, according to research to be presented to the annual conference of the European Society of Human Genetics today (Tuesday).

15 Jun 2026

ChatGPT fills gaps like a confabulator, not a hallucinating mind

A Perspective article argues that large language model errors more closely resemble confabulations, while speech recognition errors, such as unsupported Whisper transcriptions, are functionally closer to hallucinations. The authors stress that these parallels are behavioral and provisional, not evidence of shared consciousness, and suggest that psychiatric concepts could help improve AI reliability.

11 Jun 2026

Texas Children’s Hospital and Baylor researcher joins ARIA IMPACT Network to advance autism therapies

Dr. Jimmy Holder, associate professor in pediatrics at Baylor College of Medicine and Principal investigator at the Jan and Dan Duncan Neurological Research Institute at Texas Children's Hospital, and his team have received a grant for up to $17.25 million from Aligning Research to Impact Autism (ARIA) to become a part of the Innovative Medicine and Precision Approaches to Clinical Trials (IMPACT) Network.

11 Jun 2026

Remote work explains part of the post-pandemic rise in mental distress

Researchers found that workers in remote jobs spent more time alone after the COVID-19 pandemic and experienced greater psychological distress than those in non-remote jobs. The effects were strongest among people living alone, suggesting that reduced everyday social contact may be an important cost of remote work.

10 Jun 2026

New study maps early genetic disruptions in Rett syndrome

To better understand what drives the emergence of symptoms in Rett syndrome, researchers at Baylor College of Medicine and the Duncan Neurological Research Institute (Duncan NRI) at Texas Children's Hospital took a closer look at brain cells in mice modeling Rett syndrome before symptoms appeared.

10 Jun 2026

Advancing Cushing's syndrome diagnosis with salivary cortisone testing

Discover expert insights into Cushing's syndrome diagnosis using salivary cortisone testing and LC-MS/MS for improved accuracy.

From Waters Advanced Diagnostics 10 Jun 2026

NIH awards $1 million five-year grant to study the genetics of cataracts in children

Jennifer Rossen, MD, a pediatric ophthalmologist at Ann & Robert H. Lurie Children's Hospital of Chicago, recently received a $1 million five-year grant from the National Institutes of Health/National Eye Institute (NIH/NEI) to study the genetics of cataracts in children.

10 Jun 2026

Injectable semaglutide may improve fertility outcomes in PMOS

Researchers at the University of Colorado Anschutz have published a proof-of-concept study in Fertility and Sterility demonstrating that injectable semaglutide may offer meaningful reproductive benefits for women with polyendocrine metabolic ovarian syndrome (PMOS), formerly known as polycystic ovary syndrome (PCOS).

9 Jun 2026

Excess weight identified as key driver for cardiovascular-kidney-metabolic syndrome

The first-ever clinical guideline for cardiovascular-kidney-metabolic syndrome, or CKM syndrome, identifies excess weight, especially in the abdomen, as a key driver for the syndrome. T

9 Jun 2026

New clinical guidelines target interconnected heart, kidney and metabolic risks

The American Heart Association and the American College of Cardiology, along with two other leading medical organizations have developed the first-ever guideline aimed at preventing and managing cardiovascular-kidney-metabolic (CKM) syndrome, an interconnected set of health conditions that significantly increase the risk of multiorgan complications and negative cardiovascular outcomes.

9 Jun 2026

Massive genetic study uncovers new insights into anxiety risk

A study led by researchers at King’s College London and QIMR Berghofer medical research institute analysed genetic data on anxiety symptoms in 693,869 people of European ancestry, revealing new insight into the genetic pathways involved in the condition.

9 Jun 2026